Skip to content

Clinical trials

Hodgkin Disease trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Phase: Not applicable Country / region: United States Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20024
20035
20045
20056
20066
20076
20085
20094
20105
20111
20122
20132
20143
20152
20162
20192
20201
20214
20222
20233
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Terminated20
Recruiting5
Active, not recruiting4
Withdrawn3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center8
Dana-Farber Cancer Institute5
M.D. Anderson Cancer Center4
Roswell Park Cancer Institute4
St. Jude Children's Research Hospital4
Wake Forest University Health Sciences4
Baylor College of Medicine3
City of Hope Medical Center3
Masonic Cancer Center, University of Minnesota3
Memorial Sloan Kettering Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease93
Lymphoma, Non-Hodgkin69
Multiple Myeloma52
Precursor Cell Lymphoblastic Leukemia-Lymphoma49
Leukemia, Lymphocytic, Chronic, B-Cell46
Leukemia, Myeloid, Acute41
Lymphoma, Mantle-Cell39
Lymphoma36
Lymphoma, Follicular36
Lymphoma, Large B-Cell, Diffuse35

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.